DK175238B1 - Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa - Google Patents

Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa Download PDF

Info

Publication number
DK175238B1
DK175238B1 DK198702586A DK258687A DK175238B1 DK 175238 B1 DK175238 B1 DK 175238B1 DK 198702586 A DK198702586 A DK 198702586A DK 258687 A DK258687 A DK 258687A DK 175238 B1 DK175238 B1 DK 175238B1
Authority
DK
Denmark
Prior art keywords
amount
formulation
inflammatory steroid
water
peg
Prior art date
Application number
DK198702586A
Other languages
Danish (da)
English (en)
Other versions
DK258687A (da
DK258687D0 (da
Inventor
Eric Joel Benjamin
Shabbir Tyabji Anik
Ya-Yun Tracy Lin
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of DK258687D0 publication Critical patent/DK258687D0/da
Publication of DK258687A publication Critical patent/DK258687A/da
Application granted granted Critical
Publication of DK175238B1 publication Critical patent/DK175238B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198702586A 1986-05-22 1987-05-21 Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa DK175238B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/866,171 US4782047A (en) 1986-05-22 1986-05-22 Aqueous steroid formulations for nasal administration
US86617186 1986-05-22

Publications (3)

Publication Number Publication Date
DK258687D0 DK258687D0 (da) 1987-05-21
DK258687A DK258687A (da) 1987-11-23
DK175238B1 true DK175238B1 (da) 2004-07-19

Family

ID=25347059

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198702586A DK175238B1 (da) 1986-05-22 1987-05-21 Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa

Country Status (19)

Country Link
US (1) US4782047A (fi)
EP (1) EP0246652B1 (fi)
JP (1) JP2521291B2 (fi)
KR (1) KR950008308B1 (fi)
AT (1) ATE65183T1 (fi)
AU (1) AU609718B2 (fi)
CA (1) CA1288048C (fi)
DE (1) DE3771389D1 (fi)
DK (1) DK175238B1 (fi)
ES (1) ES2031467T3 (fi)
FI (1) FI88459C (fi)
GR (1) GR3002317T3 (fi)
HK (1) HK39094A (fi)
IE (1) IE60259B1 (fi)
IL (1) IL82615A (fi)
IT (1) IT1205667B (fi)
NO (1) NO173365C (fi)
NZ (1) NZ220394A (fi)
ZA (1) ZA873663B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
JPH0311016A (ja) * 1989-06-09 1991-01-18 Tokyo Tanabe Co Ltd ピリド［１，２―ａ］ピリミジン誘導体の水性製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
AU681452B2 (en) * 1993-10-21 1997-08-28 Hisamitsu Pharmaceutical Co., Inc. Pernasal composition and pernasal preparation containing thesame
US5762917A (en) * 1994-09-27 1998-06-09 Virotex Corporation Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US8466134B1 (en) 1998-06-26 2013-06-18 Athena Neurosciences, Inc. Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
GB9918559D0 (en) * 1999-08-07 1999-10-06 Glaxo Wellcome Kk Novel pharmaceutical formulation
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
JP2004505730A (ja) 2000-08-15 2004-02-26 ユニバーシティ　オブ　ケンタッキー　リサーチ　ファウンデーション プログラム可能多用量鼻腔内薬物送達デバイス
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
NZ538405A (en) 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7404489B1 (en) 2003-03-04 2008-07-29 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
DK2522365T3 (en) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
US20070111964A1 (en) * 2005-08-17 2007-05-17 Fleming And Company, Pharmaceuticals Vitamin B12 nasal spray and method of use
KR100767976B1 (ko) 2006-08-25 2007-10-18 한국유나이티드제약 주식회사 비내 건조증에 효과적인 약제학적 조성물
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
AU2008206105B2 (en) 2007-01-19 2014-04-03 Hananja Ehf Methods and compositions for the delivery of a therapeutic agent
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
US10953021B2 (en) 2013-03-15 2021-03-23 Lupin Limited Topical compositions of flunisolide and methods of treatment
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
JP6097787B2 (ja) * 2015-06-09 2017-03-15 パル ファーマシューティカル， インコーポレーテッド 鼻内送達用シアノコバラミン低粘度水性製剤
US11510859B2 (en) 2015-07-16 2022-11-29 Marinomed Biotech Ag Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
EA036233B1 (ru) 2015-07-16 2020-10-16 Мариномед Биотек Аг Способ улучшения растворимости в воде лекарственных средств, нерастворимых или слаборастворимых в воде

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2989437A (en) * 1955-06-08 1961-06-20 Upjohn Co Anti-inflammatory and anti-bacterial decongestant nasal spray compositions
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose

Also Published As

Publication number Publication date
NO173365B (no) 1993-08-30
IT1205667B (it) 1989-03-31
HK39094A (en) 1994-04-29
IE871335L (en) 1987-11-22
IL82615A0 (en) 1987-11-30
IT8720621A0 (it) 1987-05-21
GR3002317T3 (en) 1992-12-30
NO173365C (no) 1993-12-08
ZA873663B (en) 1988-12-28
FI88459B (fi) 1993-02-15
EP0246652B1 (en) 1991-07-17
NO872127D0 (no) 1987-05-21
AU7327387A (en) 1987-11-26
NO872127L (no) 1987-11-23
IL82615A (en) 1991-11-21
US4782047A (en) 1988-11-01
FI88459C (fi) 1993-05-25
FI872231A (fi) 1987-11-23
IE60259B1 (en) 1994-06-29
JP2521291B2 (ja) 1996-08-07
DK258687A (da) 1987-11-23
EP0246652A2 (en) 1987-11-25
NZ220394A (en) 1990-04-26
ATE65183T1 (de) 1991-08-15
AU609718B2 (en) 1991-05-09
KR870010862A (ko) 1987-12-18
KR950008308B1 (ko) 1995-07-27
EP0246652A3 (en) 1988-02-03
DE3771389D1 (de) 1991-08-22
CA1288048C (en) 1991-08-27
DK258687D0 (da) 1987-05-21
ES2031467T3 (es) 1992-12-16
JPS62283927A (ja) 1987-12-09
FI872231A0 (fi) 1987-05-21

Similar Documents

Publication Publication Date Title
DK175238B1 (da) Vandige steroidformuleringer, fremgangsmåde til fremstilling deraf samt anvendelse af sådanne steroidformuleringer til fremstilling af et medikament til behandling af den nasale mucosa
US4983595A (en) Aqueous steroid formulations for nasal administration
AU654397B2 (en) Pressurised aerosol compositions
JP2016053046A (ja) 共溶媒処方物
US20070218011A1 (en) Aerosol Formulation Comprising Formoterol in Suspension
US6949509B2 (en) Pharmaceutical composition containing a small or medium size peptide
US11324692B2 (en) Method to prepare pharmaceutical compositions of suggamadex
EA024475B1 (ru) Композиции витамина в12 для интраназального применения
CN101951886A (zh) 增强羟甲唑啉的光稳定性
JPH0148246B2 (fi)
CN111374942B (zh) 一种甾体类肌松药注射液及其制备方法
EA009843B1 (ru) Содержащая циклесонид стерильная водная суспензия
EP2804597A1 (en) Aqueous paracetamol composition for injection
KR20160145396A (ko) 비강 분무용 약학 조성물 및 그 제조방법
CN112957322B (zh) 一种乳酸左氧氟沙星氯化钠注射液及其制备方法
KR101506174B1 (ko) 장 청소용 약학 조성물
HU179989B (en) Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration
GB2565941A (en) A process for preparing a formulation
KR20200077818A (ko) 클로르헥시딘 또는 이의 유도체를 포함하는 항균 지속성이 개선된 알코올성 소독제
US10016428B2 (en) Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use
EP3777829B1 (en) Oral pharmaceutical solutions comprising nortriptyline hydrochloride
EP3593819A1 (en) Compositions for therapeutic uses containing 5-htp and carbidopa
US20230398129A1 (en) Crystal-free high-concentration testosterone cypionate formulations
WO2024123935A2 (en) Treatment or prevention of depressive disorders through combination therapy
EP3932391A1 (en) Method to prepare pharmaceutical compositions